While the increase in human granulomatous diseases after TNF inhibition was identified and analyzed in mouse models with relative ease, the answer to the question if the neutralization of TNF increases the chance to receive a cancer diagnosis was originally based on anecdotal evidence and the historically perceived role of TNF. This evidence concerns the gene TNF and cancer.